Anthem
Group Companies

Top quality service, timely delivery and proactive communication

Anthem
Group Companies

One stop solution for integrated drug discovery, process development and scale-up

Anthem
Group Companies

Anthem works closely with clients on IP related information

Anthem
Group Companies

The only CRO in the country with Microbiology division that provides antiinfectives screening services

Anthem
Group Companies

Proven Track Record for Hit-Identification, Hit to Lead and lead Optimization

Anthem
Group Companies

Highly qualified scientific team with diverse experience

Anthem
Group Companies

Cloning, expression and purification of recombinant proteins from both bacterial and mammalian host systems.

Overview

Anthem has created a group called “Platform Technologies” to perform innovative research that would result in proprietary assays/products. These technologies can either be offered as a service, or out-licensed to biotech, biopharmaceutical, pharmaceutical and industries in the diagnostics, nutraceutical, manufacturing, agricultural and animal healthcare sectors.

Since inception in 2008, the group has developed technologies, and is working on a number of platforms based on the need of the day in the various market sectors. This group also collaborates with other internal departments, and clients to understand potential opportunities, and suggest and design assays/products.

The innovations that have come out from this group has resulted in various recognitions and funding from Government agencies including:
  • The best innovator award by The Department of Science and Technology - Lockheed Martin India Innovation Growth Programme, 2012; this is for the cell based genotoxicity assay.
  • SBIRI (Small Business Innovation Research Initiative) funding by Department of Biotechnology, Govt. of India for developing novel production strains of bacteria.
  • BIPP 2011 grant for developing effective Biotransformation strategies to offer ‘green chemistry’ alternatives in manufacturing compounds.
The technologies are developed and validated at Anthem, and prior to release, these are also validated externally in other laboratories around the globe. Examples are two publications in peer-reviewed journals for the “ready to out-license” proprietary genotoxicity assay.
Grants & Journals
QUICK CONTACT
Name
Email ID
Contact Number
Message
CONNECT WITH US
WE ARE HERE